Clinical trials
Phase 2/3 Hematologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 4 |
| 2018 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 3 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Baxalta now part of Shire | 1 |
| Erasmus Medical Center | 1 |
| Instituto Grifols, S.A. | 1 |
| MIPO Clinic | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Taiho Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 11 |
| Hemoglobinopathies | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Anemia, Sickle Cell | 1 |
| Antithrombin III Deficiency | 1 |
| Aspergillosis | 1 |
| Blood Coagulation Disorders | 1 |
| Breast Neoplasms | 1 |
| Chediak-Higashi Syndrome | 1 |
| Coagulation Protein Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.